BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

DOV, Merck Partner In $455M Deal Focused On Depression

Aug. 9, 2004
DOV Pharmaceutical Inc. licensed worldwide rights of its triple uptake inhibitor compounds for psychiatric disorders to Merck & Co. Inc. in a deal worth $455 million, if all milestones are met. (BioWorld Today)
Read More

Stock Winners and Losers For The Week

Aug. 9, 2004

Collaborations Between Biotechnology Companies And Universities/Nonprofit Institutions: May 20 - Aug. 5, 2004

Aug. 9, 2004

Appointments And Advancements

Aug. 9, 2004

Other News To Note

Aug. 9, 2004

Racial Arguments Subsiding, BiDil Might Take On Generics

Aug. 9, 2004

BioWorld Stock Report For Public Biotechnology Companies

Aug. 9, 2004

Can NitroMed's 'Drug With Heart' Beat Two-Pill Generic Challenge?

Aug. 9, 2004

As the hippies used to remark, it's a gas.

"It," in this case, is nitric oxide, often called by the forbidding acronym NO, which first gained public acclaim when its key role in erectile function was figured out - leading boatloads of aging flower children (and others) to say "yes" to Viagra, the potency blockbuster generically known as sildenafil citrate that works by inhibiting NO's breakdown in the body.

Read More

Migrating Stem Cells Raise Hope For Stroke Treatments

Aug. 6, 2004
By Sharon Kingman

Portola Gains Cardio Program From Forebears At Millennium

Aug. 6, 2004
By Aaron Lorenzo
Growing its cardiovascular research portfolio, Portola Pharmaceuticals Inc. in-licensed an antithrombosis program from Millennium Pharmaceuticals Inc., the company from which it was spun. (BioWorld Today)
Read More
Previous 1 2 … 7369 7370 7371 7372 7373 7374 7375 7376 7377 … 10245 10246 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 30, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Roche identifies new TREM2 agonists

    BioWorld Science
    F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing